The generation of donor-specific CD4+CD25 ++CD45RA+ naive regulatory T cells in operationally tolerant patients after pediatric living-donor liver transplantation

Transplantation

Volumn 90, Issue 12, 2010, Pages 1547-1555

  Nafady Hego, Hanaa ^a,b   Li, Ying ^c   Ohe, Hidenori ^a   Zhao, Xiangdong ^a   Satoda, Naoki ^a   Sakaguchi, Shimon ^c   Wood, Kathryn ^d   Uemoto, Shinji ^a   Koshiba, Takaaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Assiut University Faculty of Medicine   (Egypt)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Humans; Living donor liver transplantation; Regulatory T cells; Tolerance

Indexed keywords

CD45RA ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; MIXED LYMPHOCYTE REACTION; PERIPHERAL LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; T CELL DEPLETION; TRANSPLANTATION TOLERANCE; UPREGULATION;

ANTIGENS, CD4; ANTIGENS, CD45; CHILD; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER TRANSPLANTATION; LIVING DONORS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES, REGULATORY;

EID: 78650808075     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f9960d     Document Type: Article

References (40)

1. Koshiba T, Li Y, Takemura M, et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric livingdonor liver transplantation. Transpl Immunol 2007; 17: 94.
2. Li Y, Koshiba T, Yoshizawa A, et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004; 4: 2118.
3. Li Y, Zhao X, Cheng D, et al. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008; 86: 1837.
4. Louis S, Braudeau C, Giral M, et al. Contrasting CD25hiCD4-T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398.
5. Braudeau C, Racape M, Giral M, et al. Variation in numbers of CD4-CD25highFOXP3- T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int 2007; 20: 845.
6. Martinez-Llordella M, Puig-Pey I, Orlando G, et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007; 7: 309.
7. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353.
8. Dieckmann D, Plottner H, Berchtold S, et al. Ex vivo isolation and characterization of CD4(-)CD25(-) T cells with regulatory properties from human blood. J Exp Med 2001; 193: 1303.
9. Taams LS, Smith J, Rustin MH, et al. Human anergic/suppressive CD4(-)CD25(-) T cells: A highly differentiated and apoptosis-prone population. Eur J Immunol 2001; 31(4): 1122.
10. Baecher-Allan C, Brown JA, Freeman GJ, et al. CD4-CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245.
11. Jonuleit H, Schmitt E, Stassen M, et al. Identification and functional characterization of human CD4(-)CD25(-) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193: 1285.
12. Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25-CD4- regulatory T cells. Int Immunol 2004; 16: 1643.
13. Valmori D, Merlo A, Souleimanian NE, et al. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest 2005; 115: 1953.
14. Seddiki N, Santner-Nanan B, Tangye SG, et al. Persistence of naive CD45RA- regulatory T cells in adult life. Blood 2006; 107: 2830.
15. Hoffmann P, Eder R, Boeld TJ, et al. Only the CD45RA- subpopulation of CD4-CD25 high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006; 108: 4260.
16. Haas J, Fritzsching B, Trubswetter P, et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 2007; 179: 1322.
17. Hoffmann P, Boeld TJ, Eder R, et al. Loss of FOXP3 expression in natural human CD4-CD25- regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009; 39: 1088.
18. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4- T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899.
19. Putnam AL, Brusko TM, Lee MR, et al. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009; 58: 652.
20. Sereti I, Imamichi H, Natarajan V, et al. In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIVinfected patients. J Clin Invest 2005; 115: 1839.
21. Fujimaki W, Takahashi N, Ohnuma K, et al. Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood. Clin Dev Immunol 2008; 2008: 305859.
22. Brusko T, Wasserfall C, McGrail K, et al. No alterations in the frequency of FOXP3- regulatory T-cells in type 1 diabetes. Diabetes 2007; 56: 604.
23. Booth NJ, McQuaid AJ, Sobande T, et al. Different proliferative potential and migratory characteristics of human CD4- regulatory T cells that express either CD45RA or CD45RO. J Immunol 2010; 184: 4317.
24. Mikulkova Z, Praksova P, Stourac P, et al. Numerical defects in CD8(-)CD28(-) T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis. Cell Immunol 2010; 262: 75.
25. Dau PC, Callahan JP. Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs. Clin Immunol Immunopathol 1994; 70: 159.
26. Abdulahad WH, van der Geld YM, Stegeman CA, et al. Persistent expansion of CD4- effector memory T cells in Wegener's granulomatosis. Kidney Int 2006; 70: 938.
27. Darmochwal-Kolarz D, Saito S, Rolinski J, et al. Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol 2007; 58: 39.
28. Venken K, Hellings N, Broekmans T, et al. Natural naive CD4-CD25- CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: Recovery of memory Treg homeostasis during disease progression. J Immunol 2008; 180: 6411.
29. Banerjee R, Mosley RL, Reynolds AD, et al. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS One 2008; 3: e2740.
30. Akl A, Jones ND, Rogers N, et al. An investigation to assess the potential of CD25high-CD4- T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Transpl Int. 2008; 21: 65.
31. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057.
32. Khattri R, Cox T, Yasayko SA, et al. An essential role for Scurfin in CD4-CD25- T regulatory cells. Nat Immunol 2003; 4: 337.
33. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4-CD25- regulatory T cells. Nat Immunol 2003; 4: 330.
34. Dai Z, Li Q, Wang Y, et al. CD4-CD25- regulatory T cells suppress allograft rejection mediated by memory CD8- T cells via a CD30- dependent mechanism. J Clin Invest 2004; 113: 310.
35. Heslan JM, Beriou G, Le Luduec JB, et al. Accumulation of T cells with potent regulatory properties and restricted Vbeta7-TCR rearrangements in tolerated allografts. Transplantation 2005; 80: 1476.
36. Guo Z, Jang MH, Otani K, et al. CD4-CD25- regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. Int Immunol 2008; 20: 307.
37. Takatsuki M, Uemoto S, Inomata Y, et al. Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance. Transpl Immunol 2001; 8: 279.
38. Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant 2006; 6: 1774.
39. Sewgobind VD, Kho MM, van der Laan LJ, et al. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients. Nephrol Dial Transplant 2009; 24: 1635.
40. Burns JP. Research in children. Crit Care Med 2003; 31(3 suppl): S131.